4//SEC Filing
Sargent Bruce J 4
Accession 0001179110-13-008953
CIK 0001065087other
Filed
May 22, 8:00 PM ET
Accepted
May 23, 3:09 PM ET
Size
8.9 KB
Accession
0001179110-13-008953
Insider Transaction Report
Form 4
Sargent Bruce J
Sr VP, Drug Discovery
Transactions
- Exercise/Conversion
Common Stock
2013-05-22$2.93/sh+7,500$21,975→ 64,590 total - Sale
Common Stock
2013-05-22$10.97/sh−7,500$82,275→ 57,090 total - Exercise/Conversion
Option to purchase Common Stock
2013-05-22$2.93/sh−7,500$21,975→ 22,500 totalExercise: $2.93Exp: 2022-02-17→ Common Stock (7,500 underlying)
Footnotes (2)
- [F1]The reported price represents the weighted average sales price for such shares. The actual range of sales prices for such shares was $10.95 - $11.00. Upon request of the Commission, the exact number of shares sold at each price will be provided.
- [F2]50% of grant is time based and 50% is performance based. Time based grant vests 25% per year on each of the first 4 anniversaries of the date of grant. Performance based grant will vest at 25% on each anniversary of the grant date through 2016 if (1) certain performance criteria related to the Company's operating profitability are reached and (2) the grantee is employed on such anniversary date. If the foregoing criteria are not met on any anniversary date, 25% of the shares of restricted stock/options under this award will immediately be forfeited. The 7,500 shares being exercised represent the first anniversary vesting of 25% of both the time based and performance based grants. The remaining 75% of each grant is not yet exercisable.
Documents
Issuer
ALBANY MOLECULAR RESEARCH INC
CIK 0001065087
Entity typeother
Related Parties
1- filerCIK 0001512062
Filing Metadata
- Form type
- 4
- Filed
- May 22, 8:00 PM ET
- Accepted
- May 23, 3:09 PM ET
- Size
- 8.9 KB